An allosteric pocket for inhibition of bacterial Enzyme I identified by NMR-based fragment screening

被引:9
|
作者
Nguyen, Trang T. [1 ]
Venditti, Vincenzo [1 ,2 ]
机构
[1] Iowa State Univ, Dept Chem, Hach Hall,2438 Pammel Dr, Ames, IA 50011 USA
[2] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA
来源
关键词
Mixed inhibition; Competitive inhibition; Antimicrobial compounds; Principal component analysis; Bacterial phosphotransferase system; TIM barrel enzyme; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; VIRULENCE GENES; PROTEIN; PHOSPHOENOLPYRUVATE; SYSTEM; PHOSPHORYLATION; LIGAND; PARAMETERIZATION;
D O I
10.1016/j.yjsbx.2020.100034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enzyme I (EI), which is the key enzyme to activate the bacterial phosphotransferase system, plays an important role in the regulation of several metabolic pathways and controls the biology of bacterial cells at multiple levels. The conservation and ubiquity of EI among different types of bacteria makes the enzyme a potential target for antimicrobial research. Here, we use NMR-based fragment screening to identify novel inhibitors of EI. We identify three molecular fragments that allosterically inhibit the phosphoryl transfer reaction catalyzed by EI by interacting with the enzyme at a surface pocket located more than 10 angstrom away from the substrate binding site. Interestingly, although the three molecules share the same binding pocket, we observe that two of the discovered EI ligands act as competitive inhibitors while the third ligand acts as a mixed inhibitor. Characterization of the EI-inhibitor complexes by NMR and Molecular Dynamics simulations reveals key interactions that perturb the fold of the active site and provides structural foundation for the different inhibitory activity of the identified molecular fragments. In particular, we show that contacts between the inhibitor and the side-chain of V292 are crucial to destabilize binding of the substrate to EI. In contrast, mixed inhibition is caused by additional contacts between the inhibitor and alpha-helix 2 that perturb the active site structure and turnover in an allosteric manner. We expect our results to provide the basis for the development of second generation allosteric inhibitors of increased potency and to suggest novel molecular strategies to combat drug-resistant infections.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] PRACTICAL ASPECTS OF NMR-BASED FRAGMENT SCREENING
    Lepre, Christopher A.
    FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 : 219 - 239
  • [2] Identification of Allosteric PIF-Pocket Ligands for PDK1 using NMR-Based Fragment Screening and 1H-15N TROSY Experiments
    Stockman, Brian J.
    Kothe, Michael
    Kohls, Darcy
    Weibley, Laura
    Connolly, Brendan J.
    Sheils, Alissa L.
    Cao, Qing
    Cheng, Alan C.
    Yang, Lily
    Kamath, Ajith V.
    Ding, Yuan-Hua
    Charlton, Maura E.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (02) : 179 - 188
  • [3] NMR-based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    Berg, Hannes
    Martin, M. A. Wirtz
    Niesteruk, A.
    Richter, C.
    Sreeramulu, S.
    Schwalbe, H.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172):
  • [4] Discovering Quality Drug Seeds by Practical NMR-based Fragment Screening
    Ayotte, Yann
    Murugesan, Jayadeepa Rajamani
    Bilodeau, Francois
    Larda, Sacha
    Bouchard, Patricia
    Drouin, Nathalie
    Morin, Melissa
    LaPlante, Steven
    PROTEIN SCIENCE, 2017, 26 : 194 - 195
  • [5] NMR-based screening: a powerful tool in fragment-based drug discovery
    Klages, Jochen
    Coles, Murray
    Kessler, Horst
    ANALYST, 2007, 132 (07) : 693 - 705
  • [6] Computer-Aided Design of Fragment Mixtures for NMR-Based Screening
    Arroyo, Xavier
    Goldflam, Michael
    Feliz, Miguel
    Belda, Ignasi
    Giralt, Ernest
    PLOS ONE, 2013, 8 (03):
  • [7] NMR-based screening: a powerful tool in fragment-based drug discovery
    Klages, Jochen
    Coles, Murray
    Kessler, Horst
    MOLECULAR BIOSYSTEMS, 2006, 2 (6-7) : 319 - 331
  • [8] Privileged molecules for protein binding identified from NMR-based screening
    Hajduk, PJ
    Bures, M
    Praestgaard, J
    Fesik, SW
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (18) : 3443 - 3447
  • [9] NMR-based screening - Preface
    Hajduk, P
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2002, 5 (08)
  • [10] NMR-based fragment screening and lead discovery accelerated by principal component analysis
    Andrew T. Namanja
    Jia Xu
    Haihong Wu
    Qi Sun
    Anup K. Upadhyay
    Chaohong Sun
    Steven R. Van Doren
    Andrew M. Petros
    Journal of Biomolecular NMR, 2019, 73 : 675 - 685